4//SEC Filing
ENDOCYTE INC 4
Accession 0001144204-13-044095
CIK 0001235007operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 7:01 PM ET
Size
16.2 KB
Accession
0001144204-13-044095
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Lovejoy Chandra D
VP of Regulatory Affairs
Transactions
- Exercise/Conversion
Common Stock
2013-08-06$3.05/sh+6,130$18,697→ 6,130 total - Exercise/Conversion
Common Stock
2013-08-06$2.54/sh+655$1,664→ 7,000 total - Exercise/Conversion
Stock Option (right to buy)
2013-08-06−6,130→ 479 totalExercise: $3.05Exp: 2017-11-14→ Common Stock (6,130 underlying) - Exercise/Conversion
Common Stock
2013-08-06$2.54/sh+215$546→ 6,345 total - Exercise/Conversion
Stock Option (right to buy)
2013-08-06−215→ 0 totalExercise: $2.54Exp: 2019-03-05→ Common Stock (215 underlying) - Exercise/Conversion
Stock Option (right to buy)
2013-08-06−655→ 0 totalExercise: $2.54Exp: 2019-08-13→ Common Stock (655 underlying) - Sale
Common Stock
2013-08-06$17.29/sh−7,000$121,030→ 0 total
Footnotes (4)
- [F1]Shares subject to the option vested 50% on November 14, 2009 and monthly over a period of 24 months beginning on November 30, 2009.
- [F2]Shares subject to the option vested monthly over a period of 48 months beginning on March 31, 2009.
- [F3]Shares subject to the option vested monthly over a period of 48 months beginning on August 31, 2009.
- [F4]Represents the sale of 7,000 shares in multiple transactions, ranging in price from $17.2701 to $17.35 per share, resulting in a weighted average sale price per share of $17.29. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 7:01 PM ET
- Size
- 16.2 KB